Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Omeros Banks on First FDA Filing Next Year, Plans to “Unlock” Inaccessible Drug Targets
|
Luke Timmerman |
11/19/09 |
Seattle
|
|
Omeros, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day
|
Luke Timmerman |
10/08/09 |
Seattle
|
|
Omeros Raises $68.2M in Washington’s First IPO in Two Years
|
Luke Timmerman |
10/08/09 |
Seattle
|
|
Omeros Teed Up for IPO Next Week, Seeking to Rake In More Than $80M
|
Luke Timmerman |
10/02/09 |
Seattle
|
|
Omeros Moves Closer to IPO, Zymo Drug Fails Arthritis Trials, Uptake Medical Gets $3.4M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/17/09 |
Seattle
|
|
Omeros Moves Closer To IPO, Sets Price Goal
|
Luke Timmerman |
09/16/09 |
Seattle
|
|
Omeros Plans to Test Waters with First Washington IPO in Two Years, Sources Say
|
Luke Timmerman |
08/26/09 |
Seattle
|
|
OrthAlign Raises $7.2M
|
Luke Timmerman |
01/07/09 |
San Diego
|
|
Omeros, Developer of Knee-Surgery Enhancer, Raises $20 Million in Debt Financing
|
Luke Timmerman |
09/25/08 |
Seattle
|
|
ConforMIS Introduces Third Implant for Arthritic Knees
|
Luke Timmerman |
08/04/08 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
